Inventor
NEBENFÜHR MARIO
AT16 patents
⚠️ This page may combine multiple inventors who share the name “NEBENFÜHR MARIO”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
VALNEVA AUSTRIA GMBH
8 patentsUS11524064B2Dec 13, 2022
Zika virus purification
VALNEVA AUSTRIA GMBH7 citations93
US11219681B2Jan 11, 2022
Zika virus vaccine
VALNEVA AUSTRIA GMBH9 citations93
US10744194B2Aug 18, 2020
Zika virus purification
VALNEVA AUSTRIA GMBH11 citations93
US11331382B2May 17, 2022
Zika virus purification
VALNEVA AUSTRIA GMBH4 citations83
US10639365B2May 5, 2020
Zika virus vaccine
VALNEVA AUSTRIA GMBH6 citations83
US12102673B2Oct 1, 2024
Zika virus vaccine
VALNEVA AUSTRIA GMBH0 citations72
US12005111B2Jun 11, 2024
Zika virus vaccine
VALNEVA AUSTRIA GMBH0 citations62
US11951163B2Apr 9, 2024
Zika virus vaccine
VALNEVA AUSTRIA GMBH0 citations62
VALNEVA SE
8 patentsUS10537630B2Jan 21, 2020
Virus purification
VALNEVA SE15 citations93
US10660950B2May 26, 2020
Virus purification
VALNEVA SE8 citations92
US11207397B2Dec 28, 2021
Virus purification
VALNEVA SE7 citations91
US11406700B2Aug 9, 2022
Virus purification
VALNEVA SE4 citations82
US12214033B2Feb 4, 2025
Virus purification
VALNEVA SE0 citations72
US12011477B2Jun 18, 2024
Method of producing pharmaceutical compositions comprising immunogenic chikungunya virus CHIKV-delta5NSP3
VALNEVA SE1 citations71
US11357846B2Jun 14, 2022
Method of producing pharmaceutical compositions comprising immunogenic chikungunya virus CHIKV-Delta5NP3
VALNEVA SE3 citations71
US12564625B2Mar 3, 2026
Method of producing pharmaceutical compositions comprising immunogenic chikungunya virus CHIKV-Δ5nsP3
VALNEVA SE0 citations61